Non-Invasive Prenatal Testing Market to Generate $9,229.2 Million Revenue by 2030, Says P&S Intelligence

NEW YORK, Oct. 12, 2022 /PRNewswire/ -- According to the latest market research study published by P&S Intelligence, in 2021, the global non-invasive prenatal testing market was worth around $3,987.1 million, which is predicted to touch $9,229.2 million at a 9.8% CAGR from 2021 to 2030. This is due to the growing cases of chromosomal abnormalities and surging requirement for early detection techniques.

Segmentation Analysis

Trisomy holds the largest share, based on application, and it is predicted to grow at the highest CAGR during the forecast period. This is owing to the growing count of females becoming pregnant at a later age, which significantly increases the danger of chromosomal abnormalities.

The consumables category holds the biggest share, of over 60%, owing to the presence of a large number of suppliers of reagents, assay kits, and disposables. The biggest share can also be attributed to the advancements in NIPT tests and a significant number of assay approvals.

Get the sample pages of this report at: https://www.psmarketresearch.com/market-analysis/non-invasive-prenatal-testing-market/report-sample

Adoption and Awareness of NIPT Are Growing in North America

• North America holds an around 45% share, and it is predicted to maintain its position in the coming years. This is due to the growing acceptance of this approach among the population, high success rates of NIPT, as well as the technological advancements and strong diagnostics infrastructure.
• In addition, the U.S. accounts for the leading position in North America, and it will advance at a rate of 8% in the future. The need for prenatal testing continues to increase due to the rising prevalence of chromosomal disorders in the U.S.
• The APAC non-invasive prenatal testing market is predicted to have considerable growth as a result of the rising need for chromosomal abnormality treatment in developing countries, such as India and China.

Increasing Use of Various Screening Techniques

Cell-free DNA in maternal plasma tests are performed the most, as this technology is highly effective in detecting the likelihood of a faulty gene. As per government sources, among the over 15,000 expecting mothers who have tested positive for genetic malformations in the fetus using NIPT, this approach has been used in almost 80%.

This technology is followed by ultrasound detection, which is often employed as complementary. While cell-free DNA in maternal plasma tests indicate the presence or likelihood of a genetic disorder, a sonograph helps gynecologists and obstetricians actually see its physical manifestation.

Browse detailed report on Global Non-Invasive Prenatal Testing Market Size, Trends and Demand Forecast Report, 2030

Rising Risk of Genetic Disorders with Increasing Maternal Age

As a woman becomes older, she may develop several medical conditions, including hypertension, reduced fertility, premature labor, stillbirths, maternal mortality, and a higher chance of miscarriage.

Hence, the number of prenatal tests is driven by the mother's advancing age, which increases the risk of genetic diseases. It is known that if the first child is born with a genetic condition, the risk rises for the second. This is because one parent serves as the carrier of the faulty gene.

Non-Invasive Prenatal Testing Market Report Coverage

By Product

• Consumables
• Assay kits & reagents
• Disposables
• Instruments
• NGS systems
• PCR instruments
• Microarrays
• Ultrasound devices
• Other instruments

By Method

• Ultrasound Detection
• Biochemical Screening
• Cell-Free DNA in Maternal Plasma Tests

By Application

• Trisomy
• Microdeletion Syndrome

By End User

• Diagnostic Laboratories
• Hospitals
• Research Institutes

Regional Analysis

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Asia-Pacific
• Japan
• China
• India
• South Korea
• Australia
• Latin America
• Brazil
• Mexico
• Middle East and Africa
• Saudi Arabia
• South Africa
• U.A.E

Browse More Reports Published by P&S

Medical Device Analytical Testing Outsourcing Market Size, Top Trends, Drivers, and Growth Forecast to 2030

IVF Devices and Consumables Market Size, Top Trends, Drivers, and Forecast Report

In Vitro Diagnostic Market Size, Top Trends, Drivers, and Growth Forecast to 2030

Genetic Testing Market Size, Top Trends, Drivers, and Growth Forecast to 2030

About P&S Intelligence

P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.

Contact:
Prajneesh Kumar
P&S Intelligence
Phone: +1-347-960-6455
Email: [email protected]
Web: https://www.psmarketresearch.com
Follow Us: LinkedIn Twitter

Logo: https://mma.prnewswire.com/media/1224988/P_and_S_Intelligence_Logo.jpg

SOURCE P&S Intelligence